Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus …

BG Nordestgaard, MJ Chapman… - European heart …, 2013 - academic.oup.com
Aims The first aim was to critically evaluate the extent to which familial
hypercholesterolaemia (FH) is underdiagnosed and undertreated. The second aim was to …

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

RT Gansevoort, R Correa-Rotter, BR Hemmelgarn… - The Lancet, 2013 - thelancet.com
Since the first description of the association between chronic kidney disease and heart
disease, many epidemiological studies have confirmed and extended this finding. As …

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European …

Task Force Members, G Montalescot… - European heart …, 2013 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

[PDF][PDF] 2013 ESH/ESC Guidelines for the management of arterial hypertension

G Mancia, R Fagard, K Narkiewicz… - Arterial …, 2013 - journals.viamedica.pl
Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and …

Authors/Task Force Members, L Rydén… - European heart …, 2013 - academic.oup.com
ESC Guidelines 3039 administrative staff and by the referees and supervisory committees of
the two organizations. It is our hope that this huge effort has generated guidelines that will …

Update on acute coronary syndromes: the pathologists' view

E Falk, M Nakano, JF Bentzon, AV Finn… - European heart …, 2013 - academic.oup.com
Although mortality rates from coronary heart disease in the western countries have declined
in the last few decades, morbidity caused by this disease is increasing and a substantial …

2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the …

TJ Anderson, J Grégoire, RA Hegele, P Couture… - Canadian Journal of …, 2013 - Elsevier
Many developments have occurred since the publication of the widely-used 2009 Canadian
Cardiovascular Society (CCS) Dyslipidemia guidelines. Here, we present an updated …

Stress and cardiovascular disease: an update on current knowledge

A Steptoe, M Kivimäki - Annual review of public health, 2013 - annualreviews.org
Considerable progress has been made during the past decade in research on
cardiovascular effects of stress. Early-life stressors, such as childhood abuse and early …

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

JR Teerlink, G Cotter, BA Davison, GM Felker… - The Lancet, 2013 - thelancet.com
Background Serelaxin, recombinant human relaxin-2, is a vasoactive peptide hormone with
many biological and haemodynamic effects. In a pilot study, serelaxin was safe and well …

High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?

O Yousuf, BD Mohanty, SS Martin, PH Joshi… - Journal of the American …, 2013 - jacc.org
The role of inflammation in the propagation of atherosclerosis and susceptibility to
cardiovascular (CV) events is well established. Of the wide array of inflammatory biomarkers …